Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease?
about
Acute graft-versus-host disease: a bench-to-bedside update.Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor ® ELMethotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG).Hematopoietic stem-cell transplantation in the developing world: experience from a center in Western IndiaHigh-dose cyclophosphamide for graft-versus-host disease prevention.The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationMesenchymal stromal cells: a new tool against graft-versus-host disease?Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part IConcise review: acute graft-versus-host disease: immunobiology, prevention, and treatment.The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate.Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future.Advances in the treatment of acute graft-versus-host disease.Intestinal aGVHD and infection after hematopoietic stem cell transplantationAcute graft-versus-host disease: are we close to bringing the bench to the bedside?Fulminant Laryngeal-tracheobronchial-pulmonary Aspergillosis: A Rare and Fatal Complication in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.Cutaneous graft-versus-host disease: rationales and treatment options.Folinic acid administration after MTX GVHD prophylaxis in pediatric allo-SCT.Thinking out of the box--new approaches to controlling GVHD.Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Is a flavonoid-rich diet with steamer cooking safe during calcineurin inhibitors therapy?70% Ethanol for Decontamination of Central Venous Lines Exposed to Calcineurin Inhibitors.Prospective evaluation of acute graft-versus-host disease
P2860
Q27687130-517D3ECA-D15A-4513-BD4C-F989272F71D0Q34313613-4F938642-4CF8-447C-982C-17E2FE799B71Q34487408-FFB0DCAA-0AFF-4338-AF48-1C8F4FA8EA4FQ34544439-CF4D2F83-A64C-4A14-AB1D-7A292C369ADBQ35097415-C8E533E8-B86A-49F6-9919-ED744DF40995Q35110765-42238424-32C2-4859-9C25-3C292B3AA660Q35571053-CEFC943F-1812-4ABE-A68F-94DD19E0FCDCQ35848391-05A81A96-278E-4067-938E-0FA0DB769F58Q36777599-99751A9B-7FC1-4868-A967-B0EFC2DFB098Q36861714-26444979-FACC-4A22-8011-FA861CDD08CCQ36862464-3E859D66-BDF1-4AAF-A0B0-3AC9B56F3D57Q36980277-B904D276-DC83-4278-88D4-45F120A49822Q37191057-03382486-3610-4E4D-BBF5-A00155D68872Q37221127-C80DFA45-788F-4DD1-A9D4-9F86E70F6AD4Q37402799-BCEF407B-4B81-4FAE-AACA-5E124A1F6B61Q37697287-353A3847-D4C5-44DC-BB4F-368270AFBAE9Q37853600-3E7AFC11-0702-454A-A201-FE33B6FC451CQ38011573-BB8C83C6-86E7-46D2-BF8C-362AF071BA1BQ38175862-B89C512E-42AD-4A2F-B8A7-93FD76B135E9Q38816505-6500F0BC-FFFE-49B3-8E77-967CFC15B818Q50454323-80429E3C-DFA0-4997-8BC6-A4F85026943BQ53733937-DD6DE42A-8FC4-4893-9E3C-82B7E2CEC765Q57117888-C3CF1DD2-07B3-4046-A817-EDD697FFF3DC
P2860
Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Should methotrexate plus calci ...... ute graft-versus-host disease?
@en
Should methotrexate plus calci ...... ute graft-versus-host disease?
@nl
type
label
Should methotrexate plus calci ...... ute graft-versus-host disease?
@en
Should methotrexate plus calci ...... ute graft-versus-host disease?
@nl
prefLabel
Should methotrexate plus calci ...... ute graft-versus-host disease?
@en
Should methotrexate plus calci ...... ute graft-versus-host disease?
@nl
P2860
P1476
Should methotrexate plus calci ...... ute graft-versus-host disease?
@en
P2093
Corey Cutler
Joseph H Antin
P2860
P304
P356
10.1016/J.BBMT.2009.10.016
P433
P577
2009-10-24T00:00:00Z